Watch AMIX. Know when insiders buy.
One email the day a filing lands. Free.
AMIX
Autonomix Medical, Inc.
4.59
−0.09 −1.92%
USD · close Sep 4
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
100
PASS · shorts 100
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $4.5MP/E —DIV YIELD —FCF YIELD —REV TTM $0NET INCOME −$16.1MNET CASH $2M52W 2.75 – 26.46SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2027 · Jun 30 | $0 | — | — | −$2.8M | −$2.7M | — | -5.02 | −$3.5M | — | — | Aug 13 |
| Q4 2026 · Mar 31derived | $0 | — | — | −$2.7M | −$2.7M | — | 0.09 | −$2.9M | $3K | −$2.9M | May 27 |
| Q3 2026 · Dec 31 | $0 | — | — | −$3.3M | −$3.3M | — | -0.36 | −$3M | $7K | −$3M | Feb 11 |
| Q2 2026 · Sep 30 | $0 | — | — | −$7.5M | −$7.5M | — | -1.38 | −$3.8M | $0 | −$3.8M | Feb 11 |
| Q1 2026 · Jun 30 | $0 | — | — | −$3.4M | −$3.3M | — | -22.69 | −$2.6M | $0 | −$2.6M | Aug 13 |
| Q4 2025 · Mar 31 | $0 | — | — | −$3.3M | −$11.4M | — | -0.74 | −$8.3M | $14K | −$8.3M | May 27 |
| Q3 2025 · Dec 31 | $0 | — | — | −$2.7M | −$2.7M | — | -1.46 | −$2.3M | $5K | −$2.3M | Feb 11 |
| Q2 2025 · Sep 30 | $0 | — | — | −$2.8M | −$2.8M | — | -2.27 | −$1.6M | $0 | −$1.6M | Feb 11 |
| Q1 2025 · Jun 30 | $0 | — | — | −$2.8M | −$2.7M | — | -2.20 | −$1.9M | $5K | −$1.9M | Feb 11 |
| Q4 2024 · Mar 31 | $0 | — | — | −$2.4M | −$15.4M | — | -14.08 | −$6.6M | $19K | −$6.7M | May 29 |
| Q3 2024 · Dec 31 | $0 | — | — | −$2.9M | −$3.1M | — | -0.23 | −$2.6M | $16K | −$2.6M | Feb 13 |
| Q2 2024 · Sep 30 | $0 | — | — | −$5.8M | −$6M | — | -8.78 | −$1.1M | $0 | −$1.1M | Feb 13 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2026 · to Mar 31 | $0 | — | −$17M | −$16.7M | — | -2.32 | −$12.3M | $10K | −$12.3M | — | — |
| FY2025 · to Mar 31 | $0 | — | −$11.6M | −$11.4M | — | -6.46 | −$8.3M | $14K | −$8.3M | — | — |
| FY2024 · to Mar 31 | $0 | — | −$12M | −$15.4M | — | -14.82 | −$6.6M | $19K | −$6.6M | — | — |
| FY2023 · to Mar 31 | $0 | — | −$2M | −$2M | — | -0.17 | −$1.9M | $0 | −$1.9M | — | — |
Every number comes from Autonomix Medical, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.